Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | -3.59% | -6.32% | +93.61% |
May. 14 | Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M | MT |
Financials (USD)
Sales 2024 * | 12.89M | Sales 2025 * | - | Capitalization | 213M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -87M | EV / Sales 2024 * | 16.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.82
x | P/E ratio 2025 * |
-2.53
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.16% |
1 day | -0.82% | ||
1 week | -4.74% | ||
Current month | -3.21% | ||
1 month | -17.35% | ||
3 months | -43.88% | ||
6 months | +120.73% | ||
Current year | +101.11% |
Managers | Title | Age | Since |
---|---|---|---|
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Pamela Connealy
DFI | Director of Finance/CFO | 62 | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Flavin
FOU | Founder | 55 | 18-06-10 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 21-08-31 |
Darren Cline
BRD | Director/Board Member | 59 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 3.485 | -3.73% | 168 681 |
24-06-05 | 3.62 | -0.82% | 317,813 |
24-06-04 | 3.65 | -2.93% | 324,449 |
24-06-03 | 3.76 | +0.53% | 234,547 |
24-05-31 | 3.74 | +0.54% | 246,197 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.11% | 213M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+2.18% | 22.67B | |
-10.09% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- PYXS Stock